GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pila Pharma AB (OSTO:PILA) » Definitions » EV-to-Revenue

Pila Pharma AB (OSTO:PILA) EV-to-Revenue : 70.01 (As of Jun. 23, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Pila Pharma AB EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Pila Pharma AB's enterprise value is kr102.43 Mil. Pila Pharma AB's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was kr1.46 Mil. Therefore, Pila Pharma AB's EV-to-Revenue for today is 70.01.

The historical rank and industry rank for Pila Pharma AB's EV-to-Revenue or its related term are showing as below:

OSTO:PILA' s EV-to-Revenue Range Over the Past 10 Years
Min: 13.95   Med: 26.06   Max: 121.18
Current: 70.01

During the past 6 years, the highest EV-to-Revenue of Pila Pharma AB was 121.18. The lowest was 13.95. And the median was 26.06.

OSTO:PILA's EV-to-Revenue is ranked worse than
80.95% of 1034 companies
in the Biotechnology industry
Industry Median: 7.69 vs OSTO:PILA: 70.01

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-23), Pila Pharma AB's stock price is kr4.29. Pila Pharma AB's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was kr0.07. Therefore, Pila Pharma AB's PS Ratio for today is 59.58.


Pila Pharma AB EV-to-Revenue Historical Data

The historical data trend for Pila Pharma AB's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pila Pharma AB EV-to-Revenue Chart

Pila Pharma AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial - - 113.04 26.44 21.95

Pila Pharma AB Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.44 20.52 26.06 22.60 21.95

Competitive Comparison of Pila Pharma AB's EV-to-Revenue

For the Biotechnology subindustry, Pila Pharma AB's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pila Pharma AB's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pila Pharma AB's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Pila Pharma AB's EV-to-Revenue falls into.



Pila Pharma AB EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Pila Pharma AB's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=102.426/1.463
=70.01

Pila Pharma AB's current Enterprise Value is kr102.43 Mil.
Pila Pharma AB's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1.46 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pila Pharma AB  (OSTO:PILA) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Pila Pharma AB's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=4.29/0.072
=59.58

Pila Pharma AB's share price for today is kr4.29.
Pila Pharma AB's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.07.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pila Pharma AB EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Pila Pharma AB's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Pila Pharma AB (OSTO:PILA) Business Description

Traded in Other Exchanges
Address
Vastergatan 1, Malmo, SWE, 211 21
Pila Pharma AB is a clinical stage pharmaceutical company. It is developing a TRPV1 antagonist, XEN-D0501, as a novel type of oral anti-diabetic agent.

Pila Pharma AB (OSTO:PILA) Headlines

No Headlines